Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Margaret B. Pulsifer has a total of 166 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transcranial Photobiomodulation on Language and Cognitive Performance in Down Syndrome: A Pilot Randomized Sham-Controlled Trial

    by Fabio Luchese, Puneet Velidi, Layane Robert Bou Jaoude, Lauren Sidelinger, Maia Gersten, Borja Ignacio Ferreras, Carlos Lohmann, Aura Maria Hurtado Puerto, Julie A. Clancy, Kayla McEachern, et al.

    Background: Down syndrome (DS) is associated with persistent language and cognitive impairments and with abnormalities in cortical oscillatory activity, including in the gamma range. Transcranial photobiomodulation (tPBM) is a noninvasive neuromodulatory intervention with potential benefits for cortical physiology, language, and cognition. Methods: We conducted a pilot randomized, double-blind, sham-controlled trial of repeated 40-Hz near-infrared tPBM in adolescents and young adults with DS. Fourteen participants were randomized 1:1 to active tPBM or sham and received 18 sessions over 6 weeks, followed by short-term and long-term follow-up. Outcomes included resting-state EEG gamma power, connected-speech measures, language and cognitive indices, and selected computerized tasks. Results: Active tPBM did not significantly increase global resting-state EEG gamma power relative to sham at either follow-up. Pre-registered analyses did not show broad treatment benefit across outcomes, although they did identify a significant short-term advantage for active tPBM on grammatical morpheme accuracy in connected speech; in contrast, picture naming favored sham at long-term follow-up. Exploratory mechanistic analyses did not show a robust biological treatment signal. Both active and sham procedures were well tolerated, with no serious adverse events. Conclusions: In this underpowered pilot sample, 6 weeks of 40-Hz near-infrared tPBM–delivered unilaterally, at low power, on target areas–did not demonstrate a meaningful effect size in DS. A dose-finding study for tPBM in DS, also accounting for age of participants, is recommended.

  • A Tale of Monozygotic Twins With Down Syndrome: Divergent Clinical Paths to Dementia

    by Giovi G. Hersch, Gabriella Leka, Gianna Eloise Acosta, Laura Xicota, Joseph H. Lee, Margaret B. Pulsifer, Christy L. Hom, Florence Lai, Herminia Diana Rosas

    Individuals with Down syndrome (DS) have a very high risk for developing Alzheimer’s disease (AD) due to the triplication of the amyloid precursor protein gene on chromosome 21. We describe a unique set of female monozygotic twins with Trisomy 21 and mild intellectual disability with significantly discordant rates of cognitive decline. The twins were followed longitudinally, starting at age 42, using cognitive assessments (Down Syndrome Mental Status Examination and Modified Cued Recall). Caregiver assessments included the Dementia Questionnaire for People with Learning Disabilities, National Task Group – Early Detection Screen for Dementia and the Neuropsychiatric Inventory. Blood was collected for AD biomarkers. Performance on baseline cognitive assessments was similar; however, by Timepoint 1, Twin 2 met criteria for mild cognitive impairment (MCI) and by Timepoint 2 met criteria for dementia due to AD. In contrast, Twin 1 remained cognitively stable. Caregiver assessment at baseline showed concerns about Twin 2’s social skills, which remained stable across timepoints. AD protein biomarker levels were similar. Discordant cognitive decline could not be explained by clinical co-morbidities, medications, or environment, suggesting that other factors, such as epigenetics, could underlie phenotypic variability and variable risk for AD in DS and deserves further study.

  • Neuropsychological profile of an adult with Down syndrome-Klinefelter syndrome

    by Alyssa W. Sullivan, Margaret B. Pulsifer

    This study describes an adult male with Down syndrome (DS) and Klinefelter syndrome (KS). Results from a comprehensive neuropsychological assessment are presented that assessed multiple domains, including general mental status, intelligence, language, visual-spatial/visual organization, attention and executive functioning, learning and memory, manual dexterity/fine motor skills, and academic skills. Information was also gathered from a self-report measure assessing current psychosocial functioning, from an informant interview documenting history, and from informant rating scales assessing adaptive skills and psychosocial, behavioral, and executive functioning. Overall, several aspects of the patient's phenotype are consistent with those seen in both DS and KS, although his developmental history, current level of intellectual and adaptive skills, and social demeanor are most consistent with individuals with DS. This study provides important insight into the phenotype, including neuropsychological profile of adults with DS-KS, which is useful for individuals, families, and clinicians living with and/or caring for adults diagnosed with this genetic condition. Future research should examine neuropsychological functioning and aging in this rare genotype.

  • Open Access

    Childhood Trauma, Cognition, and Eating Psychopathology: A Network Analysis

    by Kathryn Pasquariello, David A. Gansler, Sukanya Ray, Malvina O. Pietrzykowski, Margaret Pulsifer, Christina Ralph-Nearman

    Background/Objectives: Childhood trauma is associated with psychiatric sequelae beyond post-traumatic stress disorder (PTSD), including eating disorders (EDs) and cognitive dysfunction. While eating pathology is related to cognition irrespective of childhood trauma exposure, such experiences may influence the way in which these symptoms develop. One method that has garnered increased interest in studying the interrelationships between symptoms and pinpointing core features of psychopathology is network analysis. Methods: Using data from the Nathan Kline Institute Rockland Sample, the present study utilized network analysis to examine associations between ED symptoms and cognitive deficits among a community sample. Comorbidity networks were constructed in two samples: adult reporters of childhood trauma (n = 116) and non-reporters (n = 101). Results: In line with the cognitive-behavioral model of EDs, overvaluation of weight/shape was central to both networks but demonstrated higher strength centrality among trauma reporters. Additionally, among trauma reporters, executive functioning deficits were linked to food-related attentional biases; alternatively, affective symptoms were salient among non-reporters. Finally, negative self-concept (theorized as a putative consequence of cognitive deficits) was implicated in both networks. When comparing the networks according to global strength, we did not find significant differences. Conclusions: Our findings contribute to the literature examining the interrelatedness of eating pathology and cognition and extend these findings by considering the role of trauma exposure. While our networks shared features of overvaluation of weight/shape and negative self-concept, they differed according to cognitive-affective concomitants. This information holds clinical utility in advancing assessment and intervention for individuals with eating psychopathology.


  • Open Access

    Use of the Adaptive Behaviour Dementia Questionnaire in a Down Syndrome Specialty Clinic

    by Nicolas M. Oreskovic, Ayesha Harisinghani, Caroline Bregman, Clorinda Cottrell, Margaret Pulsifer, Brian G. Skotko, Amy Torres, Alexa Gozdiff Spognardi, Stephanie L. Santoro

    Objective: To study the use of a dementia screening tool in our clinic cohort of adults with Down syndrome. Study Design: A retrospective chart review of patients with Down syndrome was conducted to follow the use of the Adaptive Behaviour Dementia Questionnaire (ABDQ) in a dementia screening protocol. The ABDQ results for patients aged 40 years and older at a Down syndrome specialty clinic program were assessed. Based on caregiver feedback, an ABDQ with modified instructions was piloted and the impact assessed. Results: As part of our clinic’s initiative to implement a new clinical protocol to screen for dementia, the ABDQ was completed by 47 caregivers of adults with Down syndrome, aged 39 years and above, from December, 2021 to April, 2023. Based on clinical impressions at the same timepoint, the ABDQ had a sensitivity of 0%, specificity of 97.4%, positive predictive value of 0%, and negative predictive value of 80.4%. Nine patients were deemed to have mild cognitive impairment and/or dementia by clinical impressions, but they did not identify as positive on the ABDQ. The Down syndrome clinic team modified the ABDQ in an effort to provide clearer language and increased sensitivity. The modified ABDQ showed a sensitivity of 0%, specificity of 93.8%, positive predictive value of 0% and negative predictive value of 75%. Conclusion: Neither the original ABDQ nor a modified version adequately identified patients with cognitive impairment and/or dementia within the Down syndrome clinical program. The inability to replicate findings from the initial ABDQ validation may be due to differences in setting and format.


  • Open Access

    TransPhoM-DS Study Grant Report: Rationale and Protocol for Investigating the Efficacy of Low-Power Transcranial Photobiomodulation on Language, Executive Function, Attention, and Memory in Down Syndrome

    by Willians Fernando Vieira, David Richer Araujo Coelho, Maia Gersten, Aura Maria Hurtado Puerto, Stefani Kalli, Guillermo Gonzalez-Garibay, Kayla McEachern, Julie A. Clancy, Brian G. Skotko, Leonard Abbeduto, et al.

    Down syndrome (DS) is the leading genetic cause of intellectual disability globally, affecting about 1 in every 800 births. Individuals with DS often face various neuropsychiatric conditions alongside intellectual disabilities due to altered brain development. Despite the diverse phenotypic expressions of DS, typical physical characteristics frequently influence language development and acquisition. EEG studies have identified abnormal oscillatory patterns in individuals with DS. Emerging interventions targeting the enhancement of gamma (40 Hz) neuronal oscillations show potential for improving brain electrical activity and cognitive functions in this population. However, effective cognitive interventions for DS remain scarce. Extensive research indicates that transcranial photobiomodulation (t-PBM) with near-infrared (NIR) light can penetrate deeply into the cerebral cortex, modulate cortical excitability, and enhance cerebral perfusion and oxygenation. Furthermore, t-PBM has been shown to improve cognitive functions such as language, attention, inhibition, learning, and memory, including working memory. This study presents the rationale and design of an ongoing randomized, sham-controlled clinical trial aimed at assessing the effectiveness of t-PBM using NIR light in enhancing the language abilities of individuals with DS.


  • Long term neuropsychological outcomes of a pediatric ETANTR brain tumor: A case study

    by Tina Thomas, Julie A. Grieco, Margaret Pulsifer

    Survivors of pediatric brain tumors are at high risk for long-term neuropsychological difficulties. In the current case study, we present longitudinal neuropsychological data spanning 10 years (from age 9 to 19 years) of a patient with a rare, very large, bifrontal, embryonal tumor with abundant neuropil and true rosettes (ETANTR), which is typically associated with poor survivorship and significant neurological impact. Results demonstrated that the patient had largely intact cognitive functioning with specific difficulties in executive functioning, fine motor skills, and adaptive functioning at her most recent neuropsychology 10-year follow-up. These results highlight outcomes for a patient with remarkable resiliency in the context of numerous risk factors (a very large tumor size, multi-modal treatment, and seizure history). Patient protective factors (a high level of cognitive reserve, family support, and appropriate comprehensive educational services) likely contributed to the patient's favorable neuropsychological outcome. The patient's age at brain tumor diagnosis (9 years) and associated treatment was at a critical period of development for emerging higher order cognitive functions which likely impacted acquisition of executive functioning skills and secondarily adaptive skill outcomes. Consequently, pediatric brain tumor survivors with ETANTR or other frontal tumors require targeted screening of executive functions and proactive interventions.


  • Open Access

    Correction: Hom et al. Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models. Brain Sci. 2021, 11, 1220

    by Christy L. Hom, Katharine A. Kirby, Joni Ricks-Oddie, David B. Keator, Sharon J. Krinsky-McHale, Margaret B. Pulsifer, Herminia Diana Rosas, Florence Lai, Nicole Schupf, Ira T. Lott, et al.

    We would like to submit the following correction to our recently published paper

  • Open Access

    Down Syndrome: Neuropsychological Phenotype across the Lifespan

    by Margaret Pulsifer

    Down syndrome (DS), caused by triplication of chromosome 21, is the most common genetic cause of intellectual disability (ID), with an estimated incidence of one in 700 live births


  • Open Access

    Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models

    by Christy L. Hom, Katharine A. Kirby, Joni Ricks-Oddie, David B. Keator, Sharon J. Krinsky-McHale, Margaret B. Pulsifer, Herminia Diana Rosas, Florence Lai, Nicole Schupf, Ira T. Lott, et al.

    Accurate identification of the prodromal stage of Alzheimer’s disease (AD), known as mild cognitive impairment (MCI), in adults with Down syndrome (MCI-DS) has been challenging because there are no established diagnostic criteria that can be applied for people with lifelong intellectual disabilities (ID). As such, the sequence of cognitive decline in adults with DS has been difficult to ascertain, and it is possible that domain constructs characterizing cognitive function in neurotypical adults do not generalize to this high-risk population. The present study examined associations among multiple measures of cognitive function in adults with DS, either prior to or during the prodromal stage of AD to determine, through multiple statistical techniques, the measures that reflected the same underlying domains of processing. Participants included 144 adults with DS 40–82 years of age, all enrolled in a larger, multidisciplinary study examining biomarkers of AD in adults with DS. All participants had mild or moderate lifelong intellectual disabilities. Overall AD-related clinical status was rated for each individual during a personalized consensus conference that considered performance as well as health status, with 103 participants considered cognitively stable (CS) and 41 to have MCI-DS. Analyses of 17 variables derived from 10 tests of cognition indicated that performance reflected three underlying factors: language/executive function, memory, and visuomotor. All three domain composite scores significantly predicted MCI-DS status. Based upon path modeling, the language/executive function composite score was the most affected by prodromal AD. However, based upon structural equation modeling, tests assessing the latent construct of memory were the most impacted, followed by those assessing visuomotor, and then those assessing language/executive function. Our study provides clear evidence that cognitive functioning in older adults with DS can be characterized at the cognitive domain level, but the statistical methods selected and the inclusion or exclusion of certain covariates may lead to different conclusions. Best practice requires investigators to understand the internal structure of their variables and to provide evidence that their variables assess their intended constructs.